Search Results - "Nishiyama, Kuniyuki"
-
1
Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study
Published in PloS one (04-11-2022)“…Plasma and liver SerpinB1 levels are elevated in mice with insulin resistance and promote β-cell proliferation in human islets. We measured serum SerpinB1…”
Get full text
Journal Article -
2
Abdominal aortic calcification is associated with Fibrosis‐4 index and low body mass index in type 2 diabetes patients: A retrospective cross‐sectional study
Published in Journal of diabetes investigation (01-11-2022)“…Aims/Introduction This study aimed to clarify the nature of the relationship between the abdominal aortic calcification (AAC) grade and the presence of…”
Get full text
Journal Article -
3
LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand
Published in Molecular and cellular neuroscience (01-07-2014)“…Axon growth inhibitors such as Nogo proteins, myelin-associated glycoprotein (MAG), oligodendrocyte myelin glycoprotein (OMgp), and B lymphocyte stimulator…”
Get full text
Journal Article -
4
The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes
Published in Cells (Basel, Switzerland) (24-06-2021)“…Stem cell therapy using islet-like insulin-producing cells derived from human pluripotent stem cells has the potential to allow patients with type 1 diabetes…”
Get full text
Journal Article -
5
Protective effects of S100A8 on sepsis mortality: Links to sepsis risk in obesity and diabetes
Published in iScience (22-12-2022)“…Obesity and diabetes are independent risk factors for death during sepsis. S100A8, an alarmin, is related to inflammation, obesity, and diabetes. Here, we…”
Get full text
Journal Article -
6
Uncoupling protein 2 and aldolase B impact insulin release by modulating mitochondrial function and Ca2+ release from the ER
Published in iScience (15-07-2022)“…Uncoupling protein 2 (UCP2), a mitochondrial protein, is known to be upregulated in pancreatic islets of patients with type 2 diabetes (T2DM); however, the…”
Get full text
Journal Article -
7
The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1
Published in Biochemical and biophysical research communications (10-02-2012)“…► Two carboxyl-terminal regions of LOTUS bind to NgR1. ► The carboxyl-terminal regions of LOTUS block the binding of Nogo66 to NgR1. ► The carboxyl-terminal…”
Get full text
Journal Article -
8
A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database
Published in Thyroid (New York, N.Y.) (01-07-2023)“…Antithyroid drugs (ATDs) are frequently used to achieve euthyroidism in patients with hyperthyroidism. ATDs cause characteristic common and rare adverse…”
Get more information
Journal Article -
9
Vgll2 as an integrative regulator of mitochondrial function and contractility specific to skeletal muscle
Published in Journal of cellular physiology (17-09-2024)“…During skeletal muscle adaptation to physiological or pathophysiological signals, contractile apparatus and mitochondrial function are coordinated to alter…”
Get full text
Journal Article -
10
Protective Effects of Imeglimin and Metformin Combination Therapy on β-Cells in db/db Male Mice
Published in Endocrinology (Philadelphia) (26-06-2023)“…Abstract Imeglimin and metformin act in metabolic organs, including β-cells, via different mechanisms. In the present study, we investigated the impacts of…”
Get full text
Journal Article -
11
Imeglimin Ameliorates β-Cell Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway
Published in Diabetes (New York, N.Y.) (01-03-2022)“…The effects of imeglimin, a novel antidiabetes agent, on β-cell function remain unclear. Here, we unveiled the impact of imeglimin on β-cell survival…”
Get full text
Journal Article -
12
Protective Effects of Imeglimin and Metformin Combination Therapy on [beta]-Cells in db/db Male Mice
Published in Endocrinology (Philadelphia) (01-08-2023)“…Imeglimin and metformin act in metabolic organs, including [beta]-cells, via different mechanisms. In the present study, we investigated the impacts of…”
Get full text
Journal Article -
13
Uncoupling protein 2 and aldolase B impact insulin release by modulating mitochondrial function and Ca 2+ release from the ER
Published in iScience (15-07-2022)“…Uncoupling protein 2 (UCP2), a mitochondrial protein, is known to be upregulated in pancreatic islets of patients with type 2 diabetes (T2DM); however, the…”
Get full text
Journal Article -
14
Antagonistic action of LOTUS, an endogenous antagonist of Nogo receptor, to B lymphocyte stimulator-induced axon growth inhibition
Published in Neuroscience research (01-09-2011)Get full text
Journal Article -
15
Physiological roles of LOTUS, an endogenous Nogo receptor antagonist, in lateral olfactory tract formation
Published in Neuroscience research (01-09-2011)Get full text
Journal Article -
16
Promotion of neurite outgrowth by an endogenous Nogo66 receptor antagonist LOTUS
Published in Neuroscience research (01-09-2011)Get full text
Journal Article -
17
Identification of a functional domain in endogenous Nogo66 receptor antagonist LOTUS
Published in Neuroscience research (01-09-2011)Get full text
Journal Article